With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.
Guidepoint Qsight’s healthcare facilities purchasing dataset captures trends in multiple segments within the MedTech space. We break down insights on these segments and the top manufacturers in the space.
Qsight’s medical device purchasing dataset captures trends in several markets, including the orthopedics market. We took a closer look at top manufactures in the orthopedics segment to figure out which players were contributing to and detracting from overall growth of the market. Orthopedic procedures, largely elective, are more at risk to cancellations during the COVID-19…
With the Omicron COVID-19 variant sweeping across the nation, Guidepoint Qsight has gathered insights from physicians on staffing shortages and impact of Omicron at their facility. 46% physicians and administrators in our panel report that their facilities are currently understaffed and are currently hiring. Of the sites that were previously or are currently understaffed, almost…
Guidepoint Qsight’s medical device market-level dataset has captured trends in multiple MedTech market segments. Following the sharp drop at the beginning of the COVID-19 pandemic, U.S. medical device purchasing spend rebounded quickly in July 2020 back to pre-COVID-19 levels for all five market segments captured in our dataset. Segments most subject to elective procedures experienced…
Guidepoint Qsight is excited to announce the launch of a new Medical Aesthetics market intelligence offering where you can track the latest trends in the U.S. Medical Aesthetics space with insight into several categories, including Neurotoxins, Dermal Fillers, Non-Surgical Fat Reduction, Skin Tightening, Hormone Replacement Therapy, and several more. We’ve used our Medical Aesthetics dataset…
With COVID-19 continuing to create uncertainty, Guidepoint Qsight has gathered insights from U.S. physicians across healthcare markets on their expected change in procedure volumes at their facility in 2021. Collectively, over half of all physicians believe they will see higher procedure volumes in 2021 than they did in 2020. The Aesthetics market has the highest…
Since the onset of COVID-19, Guidepoint Qsight’s healthcare facilities purchasing dataset has been capturing the effects of the pandemic on several medical device manufacturers. As expected, as U.S. COVID-19 cases rose, healthcare facility purchasing declined. While all manufacturers saw a dip in healthcare facility purchasing in April 2020, some companies were able to rebound better…
Guidepoint Qsight has been monitoring the number of U.S. COVID-19 cases per capita reported by state in 2Q20 and the relationship to changes in healthcare facility medical device purchasing.
